Reuters Health Report

Click to View in Browser 09/18/2014 Death toll in West Africa Ebola epidemic reaches 2,622: WHO LONDON (Reuters) - At least 2,622 people have died in the worst outbreak of Ebola virus in history, which has so far infected at least 5,335 people in West Africa, the World Health Organization (WHO) said on Thursday. U.S. to begin Ebola hospital equipment lift to Liberia WASHINGTON (Reuters) - The first planeload of hospital equipment in the U.S. military's battle against West Africa's deadly Ebola outbreak will arrive in Liberia on Friday, a senior administration official said on Wednesday. Novo's Ryzodeg effective in type 2 diabetes treatment: study COPENHAGEN (Reuters) - Novo Nordisk's type 2 diabetes treatment Ryzodeg has proved effective in providing good blood sugar control with fewer injections than a so-called basal-bolus treatment, according to new data from a late-stage study. Boehringer to pay up to $600 million for CureVac cancer vaccine (Reuters) - Boehringer Ingelheim is betting on a cancer vaccine to fight lung tumors after signing a deal worth up to $600 million with U.S.-based CureVac, despite recent disappointments with cancer vaccines from rival firms. Bayer hits record high on move to list plastics business FRANKFURT (Reuters) - Germany's Bayer plans to list its less profitable plastics business on the stock market in a deal that could value the division at around 10 billion euros ($13 billion) as it focuses on healthcare, veterinary drugs and crop protection. Faster-acting erectile dysfunction drug gets FDA approval (Reuters) - An erectile dysfunction drug that reduces by half the time patients need to take the pill before sexual activity has been approved by the U.S. Food and Drug Administration. Merck KGaA seeks partner for immuno-oncology drug by year-end FRANKFURT (Reuters) - German drugs and chemicals maker Merck KGaA is in advanced talks with potential partners interested in its experimental cancer immunotherapy drug and expects to clinch a partnership deal before the end of the year. San Francisco lawmaker says he takes anti-HIV drug, urges wider use SAN FRANCISCO (Reuters) - An openly gay San Francisco lawmaker went public on Wednesday with his daily use of a highly effective HIV-prevention drug and urged more at-risk city dwellers to do the same. Online volunteers map uncharted Ebola zones to help save lives WASHINGTON (Thomson Reuters Foundation) - Donating to disasters used to mean writing a check to Oxfam or the Red Cross. GSK melanoma pill backed by UK cost watchdog with price cut LONDON (Reuters) - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service. Related Video Blazes continue to rip through California Wildfires rage across bone-dry California The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend